A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
12/2002
12/19/2002	WO2001068859A9 Il-17 receptor like molecules and uses thereof
12/19/2002	US20020193634 Disulfide derivatives useful for treating allergic diseases
12/19/2002	US20020193633 Mast cell stabilizers
12/19/2002	US20020193614 Treatment of cardiovascular disorders
12/19/2002	US20020193612 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
12/19/2002	US20020193441 Prostanoid therapies for the treatment of glaucoma
12/19/2002	US20020193432 Useful as modulators of the interaction between the receptor for advanced glycated end product and its ligands
12/19/2002	US20020193405 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases
12/19/2002	US20020193396 Sulfonamido ether substituted imidazoquinolines
12/19/2002	US20020193377 Quinazolines as MMP-13 inhibitors
12/19/2002	US20020193376 Administering compounds containing fused, 6-, 5-membered bicyclic heteroaromatic rings containing nitrogen as one of the two bridging atoms for decreasing intraocular pressure in an animals including humans
12/19/2002	US20020193373 Therapy of disorders of the outer retina by administering a pharmaceutically effective amount of a beta -adrenoceptor antagonist
12/19/2002	US20020193327 For therapy of eye disorders including retinitis pigmentosa, Stargardt's disease, diabetic retinopathies, retinal vascularization, or retinoblastoma
12/19/2002	US20020193306 Treatment of allergic rhinitis
12/19/2002	US20020192801 Human uridine diphosphate galactose-4-epimerase
12/19/2002	US20020192749 Human polynucleotides, polypeptides, and antibodies
12/19/2002	US20020192647 Diagnostic method
12/19/2002	US20020192280 Compositions and methods for treating inflammatory conditions utilizing protein or polysaccharide containing anti-microtubule agents
12/19/2002	US20020192216 Therapeutic use
12/19/2002	CA2450220A1 Cyclopentane heptan (ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension
12/19/2002	CA2450027A1 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
12/19/2002	CA2449934A1 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
12/19/2002	CA2449213A1 Ophthalmic compositions comprising hyaluronic acid
12/19/2002	CA2445471A1 Quinuclidine-substituted heteroaromatic compounds as ligands at nicotic acetylcholine receptors
12/19/2002	CA2445467A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease
12/18/2002	EP1267171A1 Cofactor-based screening method for nuclear receptor modulators
12/18/2002	EP1266014A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
12/18/2002	EP1266013A2 Heparinase iii and uses thereof
12/18/2002	EP1266012A2 Proteases
12/18/2002	EP1266002A2 Il-17 receptor like molecules and uses thereof
12/18/2002	EP1266001A2 Human transcription factors
12/18/2002	EP1265903A1 Thiepino[3,2-b]dihydropyridines and related compositions and methods
12/18/2002	EP1265900A1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
12/18/2002	EP1265899A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
12/18/2002	EP1265896A1 4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents
12/18/2002	EP1265891A2 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
12/18/2002	EP1265878A1 A process for the preparation of epothiline analogs and intermediates
12/18/2002	EP1265866A2 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
12/18/2002	EP1265865A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors
12/18/2002	EP1265862A2 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
12/18/2002	EP1265860A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
12/18/2002	EP1265859A2 Amidino compounds useful as nitric oxide synthase inhibitors
12/18/2002	EP1265853A1 Carboxylic acid derivatives as ip antagonists
12/18/2002	EP1265848A2 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
12/18/2002	EP1265839A1 Compounds active at the glucocorticoid receptor
12/18/2002	EP1265636A2 Improved treatment of neovascularization
12/18/2002	EP1265627A2 Methods and compositions for inhibiting angiogenesis
12/18/2002	EP1265615A2 Novel combination of non-sedative anti-histamines containing substances which influence the action of leukotriene, for treating rhinitis/conjunctivitis
12/18/2002	EP1265606A1 Cell adhesion inhibitors
12/18/2002	EP1265603A2 Il-8 receptor antagonists
12/18/2002	EP1265601A2 Method for treating ocular pain
12/18/2002	EP1086101B1 Beta-carboline compounds
12/18/2002	EP0948349B1 in vitro methods and use of pharmaceutical compositions for the TREATMENT OF INNER EAR HAIR CELLS
12/18/2002	EP0934300B1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
12/18/2002	EP0882038B1 substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
12/18/2002	EP0873309B1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands
12/18/2002	EP0866803B1 Transferrin receptor protein of moraxella
12/18/2002	EP0859784B1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation
12/18/2002	EP0788792B1 Matrix type patch preparation
12/18/2002	CN1096460C Novel substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for treatment of allergic diseases
12/18/2002	CA2388761A1 Wound healing biomarkers
12/17/2002	WO2001097852A1 Aseptics
12/17/2002	US6495608 Methods of performing surgery with galactomannan polymers and borate
12/17/2002	US6495599 Nutrients, nervous system development
12/17/2002	US6495571 Administering to the mammal an effective cancer treatment amount of the compound 3,5-dichloro-4,6-diethoxy-2-(trichloromethyl)pyridine or and acid addition salt to treat the cancer
12/17/2002	US6495565 For therapy of acute infection, acute phase response, age related macular degeneration, alcoholism, anorexia, asthma, autoimmune disease, autoimmune hepatitis, bechet's disease, cachexia, calcium pyrophosphate dihydrtate deposition
12/17/2002	US6495564 Such as 3-(6-((4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl)-1-methyl-2-oxo-1,2-dihydro-quinolin-4-yl)-benzaldehyde o-methyl-oxime; inhibiting abnormal cell growth
12/17/2002	US6495563 Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula
12/17/2002	US6495555 Tricyclic Δ-3-piperidines as α2-antagonists
12/17/2002	US6495552 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid.
12/17/2002	US6495544 Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase
12/17/2002	US6495522 Substituted alpha-hydroxy acid caspase inhibitors and the use thereof
12/17/2002	US6495516 Method for killing gram-negative bacteria with biologically active peptides from functional domains of bacterial/permeability-increasing protein
12/14/2002	CA2390686A1 Cofactor-based screening method for nuclear receptor modulators and related modulators
12/12/2002	WO2002099115A2 Nucleic acid-associated proteins
12/12/2002	WO2002098880A1 5-ethyl-imidazotriazinones
12/12/2002	WO2002098877A1 Pyrazino 1',2':1,6 pyrido 3,4-b indole1,4-dione derivatives
12/12/2002	WO2002098875A1 Carboline derivatives as pde-5 inhibitors
12/12/2002	WO2002098873A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002	WO2002098868A1 Epothilone derivatives
12/12/2002	WO2002098864A1 Pyrimidine, triazine and pyrazine derivatives as glutamate receptors
12/12/2002	WO2002098860A1 Novel fused indazoles and indoles and their use for the treatment of glaucoma
12/12/2002	WO2002098482A2 System for osmotic delivery of pharmaceutically active agents
12/12/2002	WO2002098460A1 Compositions and methods for treating hyperimmune response in the eye
12/12/2002	WO2002098438A1 Compositions containing an active fraction isolated from scutellariae barbatae and methods of use
12/12/2002	WO2002098428A1 Tetracyclic compounds as pde5-inhibitors
12/12/2002	WO2002098400A1 Novel arylaminopropane analogues and their use for the treatment of glaucoma
12/12/2002	WO2002098350A2 Pyranoindazoles and their use for the treatment of glaucoma
12/12/2002	WO2002098345A1 Use of an antioxidant for treating and/or preventing surface ocular disorders
12/12/2002	WO2002098278A2 Peripheral blood fibrocytes differentiation pathway and migration to wound sites
12/12/2002	WO2002087595A8 Treating retinal or photoreceptor degenerative diseases
12/12/2002	WO2002076977A3 Rho-kinase inhibitors
12/12/2002	WO2002076976A3 Rho-kinase inhibitors
12/12/2002	WO2002064591A3 Carboline derivatives
12/12/2002	WO2002062792A9 Jnk inhibitor
12/12/2002	WO2002061052A3 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
12/12/2002	WO2002002775A3 Calpain protease 12
12/12/2002	WO2001097850A3 Combinations and compositions which interfere with vegf/vegf and angiopoietin/tie receptor function and their use (ii)
12/12/2002	WO2001095922A1 Remedies for allergic diseases and process for producing the same
12/12/2002	US20020188124 Novel spiro compounds

1 ... 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 ... 531